Anna Thomas, executive vice president, was interviewed in Specialty Pharmacy Continuum on the lack of an “accountable owner” among rare disease service providers and the need for better patient care pathways. To read the full article, please visit here.
Tag: rare disease
Rare Disease Newsletter Series
As part of an enduring commitment to raise rare disease awareness, The Kinetix Group (TKG) presents a series of educational newsletters. Newsletter #1 Newsletter #2 Newsletter #3 Newsletter #4 Newsletter #5
Anna Thomas Presents at AMGA 2023
Anna Thomas, executive vice president, presented in a virtual panel, “Disrupting Rare Disease Patient Outcomes through Innovation,” for the American Medical Group Association (AMGA).